The current valuation score of Scinai Immunotherapeutics Ltd is 7.47, ranking 232 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.06, which is -1119.50% below the recent high of 0.66 and -221.83% above the recent low of -0.21.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.